1. A solid state disk module comprising:
a) an IDE interface located on a circuit board and connecting the disk module to a main board of a computer, the IDE interface having an extending interface;
b) a flash memory controller electrically connected to the IDE interface, and controlling data access and specifying an address for data storage;
c) a flash memory array having a plurality of flash memories, the flash memory array being connected to the flash memory controller for saving data, the flash memory controller and the flash memory array are electrically connected to the circuit board, the flash memory controller and the flash memory array are enclosed by a casing; and
d) a power source having a power input terminal and a power output terminal and connected to the flash memory controller and the flash memory array to supply a working voltage, wherein the power source is integrally formed with the IDE interface as a single connector.
2. The solid state disk module according to claim 1, wherein the flash memory controller is a single chip controller.
3. The solid state disk module according to claim 1, wherein the flash memory controller is an MX9691 controller.
4. The solid state disk module according to claim 1, wherein the plurality of flash memories comprises ten flash memories divided into five groups.
5. The solid state disk module according to claim 1, wherein the IDE interface is electrically connected to the circuit board.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of the formula
wherein A is \u2014(C\u2550O)NH\u2014 or \u2014NH(C\u2550O)\u2014;
X, Y and Z are \u2550(CR6)\u2014, \u2550(CR7)\u2014, and \u2550(CR8)\u2014;
R1 is a 3-oxo-2,3-dihydro-benzo1,4thiazin-4-yl group
n is an integer from zero to two;
q is an integer one or two;
s is an integer from one to three;
R2 is chloro, bromo, (C1\u2013C4)alkyl, \u2014CF3 or \u2014CN;
R3 is selected from the group consisting of (C4\u2013C10)alkyl, (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014, (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014; (C1\u2013C10)heterocyclyl-(CR11R12)s\u2014 and (C1\u2013C10)heteroaryl-(CR11R12)s\u2014; wherein said (C4\u2013C10)alkyl may optionally be substituted with one to three substituents independently selected from halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, \u2014CO2\u2014(C1\u2013C4)alkyl, formyl, (C1\u2013C4)alkyl-(C\u2550O)\u2014, (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein each of said R3 group members (C1\u2013C10)heterocyclyl(CR11R12)s\u2014 and (C1\u2013C10)heteroaryl(CR11R12)s\u2014 contain one to three heteroatoms independently selected from \u2014O\u2014 and \u2014S(O)n\u2014; wherein each of said R3 group members (C3\u2013C12)cycloalkyl(CR11R12)s\u2014, (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014, (C1\u2013C10)heterocyclyl(CR11R12)s\u2014 and (C1\u2013C10)heteroaryl(CR11R12)s\u2014 may optionally be substituted on any ring carbon atom able to support an additional substituent, by one to four substituents per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, (C1\u2013C4)alkyl-(C\u2550O)\u2014, (C8\u2013C10)aryl, (C8\u2013C10)aryl2-CH\u2014, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, benzyl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein said R3 group members (C3\u2013C8)cycloalkyl(CR11R12)s\u2014 and (C1\u2013C10)heterocyclyl(CR11R12)s\u2014 may also optionally be substituted by oxo; wherein each of the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl anywhere on said R3 substituents may optionally be substituted on any ring carbon atom by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, amino, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-NH\u2014, (C1\u2013C4)alkyl2-N\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014;
R6, R7 and R8 are each independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, (C1\u2013C6)alkyl optionally substituted by one to four chloro or fluoro, and (C1\u2013C6)alkyloxy optionally substituted by one to four chloro or fluoro;
R11 and R12 are each independently selected from the group consisting of hydrogen, fluoro, cyano, hydroxyl, \u2014CF3, CF3O\u2014, (C1\u2013C6)alkyl, (C3\u2013C8)cycloalkyl, (C1\u2013C6)alkyloxy, (C3\u2013C8)cycloalkyloxy, phenyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl; wherein said (C1\u2013C6)alkyl, (C3\u2013C8)cycloalkyl, (C1\u2013C6)alkyloxy, (C3\u2013C8)cycloalkyloxy phenyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl may optionally be substituted by one to three substituents independently selected from chloro, fluoro, cyano, hydroxyl, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, or (C1\u2013C4)alkyl-(C\u2550O)\u2014,
with the proviso that when said R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014; R1 and R2 are each hydrogen; and s is one or two; then said (C3\u2013C12)cycloalkyl must be other than optionally substituted adamantyl;
or a pharmaceutically acceptable salt thereof.
2. A compound according to claim 1 wherein X, Y and Z are \u2550(CR6)\u2014, \u2550(CR7)\u2014, and \u2550(CR8)\u2014, respectively; and each of R6, R7 and R8 is hydrogen.
3. A compound according to claim 2, wherein A is \u2014(C\u2550O)NH\u2014.
4. A compound according to claim 2, wherein A is \u2014NH(C\u2550O)\u2014.
5. A compound according to claim 3, wherein R3 is (C4\u2013C10)alkyl.
6. A compound according to claim 3, wherein R3 is (C4\u2013C10)alkyl substituted with one to three substituents independently selected from halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
7. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 wherein R11 and R12 are each independently hydrogen or (C1\u2013C4)alkyl.
8. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 wherein at least one of R11 and R12 is other than hydrogen or (C1\u2013C4)alkyl.
9. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 optionally substituted by one to three substituents independently selected from the group consisting of hydrogen, halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, oxo, \u2014CO2\u2014(C1\u2013C4)alkyl, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
10. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 optionally substituted by one to three substituents independently selected from the group consisting of hydrogen, halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl and (C1\u2013C4)alkoxy.
11. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 optionally substituted by at least one substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein each of the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl anywhere on said (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 substituents may optionally be substituted by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, \u2014CO2\u2014(C1\u2013C4)alkyl, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
12. A compound according to claim 3, wherein R3 is (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 optionally substituted by at least one spiro substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein each of the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl spiro substituent on said (C3\u2013C12)cycloalkyl-(CR11R12)s\u2014 may optionally be substituted by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, \u2014CO2\u2014(C1\u2013C4)alkyl, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
13. A compound according to claim 3, wherein R3 is (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014; wherein R11 and R12 are each independently hydrogen or (C1\u2013C4)alkyl.
14. A compound according to claim 3, wherein R3 is (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014; wherein R11 and R12 are each independently selected from the group consisting of hydrogen and (C1\u2013C4)alkyl and wherein each of R11 and R12 of the CR11 R12 directly attached to group A are hydrogen; and wherein said (C6\u2013C10)aryl of said (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014 group member is substituted by one to three substituents independently selected from the group consisting of hydrogen, halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, oxo, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, benzyloxy and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
15. A compound according to claim 3, wherein R3 is (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014; wherein R11 and R12 are each independently selected from the group consisting of hydrogen and (C1\u2013C4)alkyl; and wherein said (C6\u2013C10)aryl of said (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014 group member is substituted by one to three substituents independently selected from the group consisting of hydrogen, halo, \u2014CN, (C1\u2013C4)alkyl, benzyloxy and (C1\u2013C4)alkoxy.
16. A compound according to claim 3, wherein R3 is (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014; wherein R11 and R12 are each independently selected from the group consisting of hydrogen and (C1\u2013C4)alkyl; and wherein said (C6\u2013C10)aryl of said (C6\u2013C10)aryl-(CR11R12)q\u2014(CH2)\u2014 group member is substituted by at least one substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein each of the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl and (C1\u2013C10)heterocyclyl substituents may optionally be substituted by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, benzyloxy and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
17. A compound according to claim 3, wherein R3 is (C1\u2013C10)heteroaryl-(CR11R12)s\u2014 optionally substituted on any carbon atom able to support an additional substituent by one to three substituents per ring independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
18. A compound according to claim 3, wherein R3 is (C1\u2013C10)heteroaryl-(CR11R12)s\u2014 optionally substituted on any carbon atom able to support an additional substituent by one to three substituents per ring independently selected from the group consisting of halo, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
19. A compound according to claim 3, wherein R3 is (C1\u2013C10)heteroaryl-(CR11R12)s\u2014 optionally substituted on at least one carbon atom able to support an additional substituent by a substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014 substituents may optionally be substituted on any ring carbon atom by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
20. A compound according to claim 3, wherein R3 is (C1\u2013C10)heterocyclyl-(CR11R12)s\u2014 optionally substituted on any carbon atom able to support an additional substituent by one to three substituents per ring independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, oxo, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
21. A compound according to claim 3, wherein R3 is (C1\u2013C10)heterocyclyl-(CR11R12)s\u2014 optionally substituted on any carbon atom able to support an additional substituent by one to three substituents per ring independently selected from the group consisting of halo, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, oxo, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
22. A compound according to claim 3, wherein R3 is (C1\u2013C10)heterocyclyl-(CR11R12)s\u2014 optionally substituted on at least one carbon atom able to support an additional substituent by a substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014substituents may optionally be substituted on any ring carbon atom by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
23. A compound according to claim 3, wherein R3 is (C1\u2013C10)heterocyclyl-(CR11R12)s\u2014 optionally substituted on at least one carbon atom able to support an additional substituent by a spiro substituent selected from the group consisting of (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014; wherein the aforesaid (C6\u2013C10)aryl, (C3\u2013C8)cycloalkyl, (C1\u2013C10)heteroaryl, (C1\u2013C10)heterocyclyl, (C6\u2013C10)aryl-O\u2014, (C3\u2013C8)cycloalkyl-O\u2014, (C1\u2013C10)heteroaryl-O\u2014 and (C1\u2013C10)heterocyclyl-O\u2014 spiro substituents may optionally be substituted on any ring carbon atom by one to three moieties per ring, independently selected from the group consisting of halo, hydroxy, \u2014CN, (C1\u2013C4)alkyl, (C1\u2013C4)alkoxy, \u2014CF3, CF3O\u2014, (C1\u2013C4)alkyl-S\u2014, (C1\u2013C4)alkyl-(S\u2550O)\u2014, (C1\u2013C4)alkyl-(SO2)\u2014, (C1\u2013C4)alkyl-O\u2014(C\u2550O)\u2014, formyl, and (C1\u2013C4)alkyl-(C\u2550O)\u2014.
24. A compound according to claim 2, wherein R2 is chloro or bromo.
25. A compound according to claim 2, wherein R2 is chloro.
26. A compound according to claim 2, wherein R2 is (C1\u2013C4)alkyl or \u2014CN.
27. A compound according to claim 2, wherein R2 is hydroxy.
28. A compound according to claim 1, wherein R7 is other than hydrogen.
29. A compound according to claim 1, wherein said compound is 2-Chloro-N-2-(2-chloro-phenyl)-ethyl-5-(3-oxo-2,3-dihydro-benzo1,4thiazin-4-yl)-benzamide or a pharmaceutically acceptable salt thereof.
30. A method for treating arthritis in a mammal comprising administering to said mammal an amount of a compound according to claim 1, effective in treating arthritis.
31. A pharmaceutical composition for the treatment of arthritis in a mammal-comprising an amount of a compound according to claim 1, effective in treating arthritis and a pharmaceutically acceptable carrier.